Advisor Group Holdings, Inc. Chimerix Inc Transaction History

Advisor Group Holdings, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.94 - $1.23 $11,783 - $15,419	12,536 Added 66.39%	31,417 $30,000
Q2 2023 Aug 10, 2023	BUY	$1.1 - $1.54 $5,870 - $8,218	5,337 Added 39.4%	18,881 $22,000
Q1 2023 May 12, 2023	BUY	$1.19 - $2.09 $9,422 - $16,548	7,918 Added 140.74%	13,544 $17,000
Q4 2022 Feb 10, 2023	SELL	$1.67 - $2.35 $738 - $1,038	-442 Reduced 7.28%	5,626 $10,000
Q3 2022 Nov 14, 2022	SELL	$1.81 - $2.76 $1,659 - $2,530	-917 Reduced 13.13%	6,068 $11,000
Q2 2022 Aug 10, 2022	SELL	$1.34 - $5.34 $6,899 - $27,495	-5,149 Reduced 42.43%	6,985 $14,000
Q1 2022 May 04, 2022	BUY	$4.58 - $6.8 $26,994 - $40,079	5,894 Added 94.46%	12,134 $56,000
Q2 2021 Aug 02, 2021	BUY	$7.54 - $9.79 $22,514 - $29,232	2,986 Added 91.76%	6,240 $50,000
Q1 2021 May 13, 2021	SELL	$4.76 - $11.25 $35,566 - $84,060	-7,472 Reduced 69.66%	3,254 $31,000
Q4 2020 Feb 10, 2021	SELL	$2.43 - $5.42 $6,050 - $13,495	-2,490 Reduced 18.84%	10,726 $51,000
Q3 2020 Nov 12, 2020	BUY	$2.3 - $3.72 $23,496 - $38,003	10,216 Added 340.53%	13,216 $32,000
Q2 2020 Aug 14, 2020	BUY	$1.33 - $3.63 $3,524 - $9,619	2,650 Added 757.14%	3,000 $9,000
Q1 2020 May 18, 2020	BUY	$1.27 - $2.33 $444 - $815	350 New	350 $1,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.